These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10442521)

  • 1. The role of immunoglobulin therapy in allergic diseases.
    Rabinovitch N; Gelfand EW; Leung DY
    Allergy; 1999 Jul; 54(7):662-8. PubMed ID: 10442521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of immunoglobulin preparations in treatment of allergic diseases].
    Boznański A; Widerska A
    Postepy Hig Med Dosw; 2002; 56 Suppl():41-7. PubMed ID: 12661413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.
    Wakim M; Alazard M; Yajima A; Speights D; Saxon A; Stiehm ER
    Ann Allergy Asthma Immunol; 1998 Aug; 81(2):153-8. PubMed ID: 9723561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immune globulin: an alternative therapy in steroid-dependent allergic diseases.
    Gelfand EW; Landwehr LP; Esterl B; Mazer B
    Clin Exp Immunol; 1996 May; 104 Suppl 1():61-6. PubMed ID: 8625546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin therapy for the treatment of severe atopic dermatitis.
    Lamb SR; Rademaker M
    Expert Opin Pharmacother; 2001 Jan; 2(1):67-74. PubMed ID: 11336569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin attenuates airway hyperresponsiveness in a murine model of allergic asthma.
    Kaufman GN; Massoud AH; Audusseau S; Banville-Langelier AA; Wang Y; Guay J; Garellek JA; Mourad W; Piccirillo CA; McCusker C; Mazer BD
    Clin Exp Allergy; 2011 May; 41(5):718-28. PubMed ID: 21255135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin therapy in dermatologic disorders.
    Cakmak SK; Gül U; Gönül M; Kiliç A; Soylu S
    Inflamm Allergy Drug Targets; 2008 Jun; 7(2):75-84. PubMed ID: 18691136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms.
    Wong PH; White KM
    Clin Rev Allergy Immunol; 2016 Dec; 51(3):303-314. PubMed ID: 26142065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin.
    Spahn JD; Leung DY; Chan MT; Szefler SJ; Gelfand EW
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):421-6. PubMed ID: 10069875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of serum levels of interleukin-2, intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1 and Th1 and Th2 cell in severe atopic dermatitis after intravenous immunoglobulin therapy.
    Huang JL; Lee WY; Chen LC; Kuo ML; Hsieh KH
    Ann Allergy Asthma Immunol; 2000 Mar; 84(3):345-52. PubMed ID: 10752921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose immunoglobulin therapy as an immunomodulatory treatment of rheumatoid arthritis.
    Tumiati B; Casoli P; Veneziani M; Rinaldi G
    Arthritis Rheum; 1992 Oct; 35(10):1126-33. PubMed ID: 1418003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin to treat severe atopic dermatitis in children: a case series.
    Turner PJ; Kakakios A; Wong LC; Wong M; Campbell DE
    Pediatr Dermatol; 2012; 29(2):177-81. PubMed ID: 22085141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravenous immunoglobulin for neonates with severe enteroviral infections with emphasis on the timing of administration.
    Yen MH; Huang YC; Chen MC; Liu CC; Chiu NC; Lien R; Chang LY; Chiu CH; Tsao KC; Lin TY
    J Clin Virol; 2015 Mar; 64():92-6. PubMed ID: 25728086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alteration of cytokines in serum and cerebrospinal fluid before and after high-dose immunoglobulin therapy in patients with West syndrome].
    Matsuura R; Hamano SI; Hirata Y; Oba A; Kumagai Y; Suzuki K; Koichihara R; Kikuchi K; Tanaka M; Minamitani M
    No To Hattatsu; 2016 Jul; 48(4):247-51. PubMed ID: 30010305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [TREATMENT OF REFRACTORY RHINOSINUSITIS IN PATIENTS WITH IGE-DEFICIENCY].
    Tsaryk VV
    Lik Sprava; 2014 Dec; (12):3-10. PubMed ID: 26638461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravenous immunoglobulin therapy for kidney diseases in children].
    Zwolińska D
    Pol Merkur Lekarski; 2011 Jun; 30(180):423-6. PubMed ID: 21751552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and availability of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy].
    Iijima M; Koike H; Sobue G
    Nihon Rinsho; 2012 Apr; 70(4):715-21. PubMed ID: 22568158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infections.
    Ferrara G; Zumla A; Maeurer M
    Am J Med; 2012 Oct; 125(10):1036.e1-8. PubMed ID: 22608788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
    Rütter A; Luger TA
    Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.